by this time johnson johnson had already spent on the project the ibot entered clinical trials in 1999 with fda approval arriving four years after the reveal on august 13 2003 during development the ibot was nicknamed fred after fred astaire the segway pt which was the result of the non medical product development was nicknamed ginger after ginger rogers fred astaire s dance partner was released in 2001 starting in 2009 the ibot was no longer available for sale from independence technology but support for existing units was available until the end of 2013 production was discontinued for cost reasons only a few hundred were sold per year at a retail price of about 25 000 and medicare paid 5000 in 2011 dean kamen the inventor of the ibot stated his support of america s huey 091 foundation s effort to reinstate ibot production in late 2014 kamen announced that the fda had reclassified the ibot from a class iii to a class ii medical device this lowering of regulatory controls will allow deka to revive the long dormant ibot and immediately start building a next generation product kamen said the model would be out in less than two